Lowering Medicare Drug Prices

The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week.

2019-01-24T17:59:12+00:00January 24th, 2019|Categories: News|

No ‘legacy effect’

Long-term follow-up of a major VA diabetes study shows that patients who received intensive therapy to lower blood sugar levels did not see a significant drop, on average, in heart attacks, strokes, and other cardiovascular events.

2018-11-27T17:18:41+00:00November 27th, 2018|Categories: News|